Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_assertion description "[Small-molecule inhibitors that are capable of inhibiting the activity of Bcl-2 and Bcl-X(L) may have great therapeutic potential as an entirely new class of anticancer drugs for treating many forms of cancers in which Bcl-2 and/or Bcl-X(L) proteins are overexpressed and for which traditional therapies are ineffective.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_assertion evidence source_evidence_literature NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_assertion SIO_000772 14613034 NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_assertion wasDerivedFrom befree-20150227 NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_assertion wasGeneratedBy ECO_0000203 NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP811143.RAYU3cm9Px1XOVlXBOBUahQnPhnAtZ6WUtK-m8vHMwrCo130_provenance.